26 March 2019
SpeeDx joins Texas CoLab
SpeeDx have successfully started their U.S. journey by joining the Texas Health CoLab in Austin Texas. Chosen for its synergy...
19 March 2019
SpeeDx sign Middle East Distributor
New distribution partners, Al Zahrawi Medical Supplies LLC, will distribute SpeeDx ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman,...
15 February 2019
TGA clearance for ResistancePlus® GC
ResistancePlus® GC received clearance from the Australian Therapeutic Goods Administration (TGA) today. Launched in December with CE-IVD mark for sale...
13 February 2019
SpeeDx Develops Multiplex Test for Respiratory Viruses
SpeeDx announced submission of the PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA), with anticipated clearance in time for...
8 February 2019
New test for STI in a bid to stop superbug
An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment...
4 February 2019
Treat gonorrhoea with Resistance Guided Therapy
Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible...
